Select Page

COVID-19 update: Nov. 18, 2021

COVID-19 update: Nov. 18, 2021

COVID-19 Vaccine: What does it mean for transplanted children?

Transplant Families and the American Society of Transplantation (AST) recently held a webinar for parents of pediatric organ recipients to share information related to the COVID-19 vaccination and children. Topics included:

  • Vaccination of pediatric transplant recipients (ages 5-11) and the importance of encouraging vaccination for those around them
  • Information on what the transplant infectious diseases community has learned, and specific medical effects COVID-19 may have on pediatric patients
  • Vaccine-induced myocarditis

View the webinar here.


Updated CDC guidance addresses potential COVID-19 vaccine booster for some immunocompromised people

The U.S. Centers for Disease Control and Prevention (CDC) has updated interim guidance regarding COVID-19 vaccination for moderately to severely immunocompromised people. The guidance says, that at the discretion of the clinical team, a booster for immunocompromised adults may be provided six months or more after they have received a third dose of an mRNA vaccine, or at least two months after they have received a Johnson & Johnson vaccine. For more detail, read the CDC guidance.

ASTS position statement on the role of COVID-19 vaccination for transplant candidates and recipients

The American Society of Transplant Surgeons continues to recommend routine vaccination for all organ recipients (along with timely boosters). It also recommends vaccines for those on the waiting list (if possible within time limitations). These recommendations are consistent with ASTS’ existing “routine standards of care,” which focus on patient safety by reducing known infectious disease prior to organ transplantation. Read more here.

Committee meetings

The health and safety of OPTN members is a priority for UNOS. The list of all scheduled meetings will be updated on the calendar of events to reflect updates related to in-person vs. virtual meetings.

OPTN Summary of Evidence on COVID-19 updated

The OPTN Summary of Evidence on SARS-CoV-2 has been updated to reflect review of additional evidence, including discussion of the Delta variant and of post-implementation data from the emergency lower respiratory testing policy.


The latest data on organ donation and transplant in the U.S.

High-level data on transplants, deceased donors recovered, patients added to the waitlist and patients temporarily moved to inactive waitlist status.

International organ donation and transplantation Town Hall

On Oct. 4, a number of transplant organizations from around the world continued their partnership to share experiences to date and respond to questions about COVID-19 and the vaccine. Watch the recording here.

Updated COVID-19 FAQs for patients

As the pandemic continues to impact our lifesaving mission, find our newly updated list of frequently asked questions and answers on Transplant Living.

American Society of Transplantation Spanish language COVID-19 resources

Spanish language COVID-19 resources from AST, including a COVID-19 Vaccines for Hispanic Patients and Transplants recording.  


For COVID-19 related policy and operational questions, email [email protected]

Share This